Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Long-term cost-effectiveness of clopidogrel in STEMI patients
International Journal of Cardiology, 06/29/09
Zhang Z et al. - Addition of clopidogrel to aspirin, given up to 1 year, in the setting of STEMI is a highly cost-effective strategy.
Related Articles
A Comparison of Clopidogrel Responsiveness in Patients With Versus Without Chronic Renal Failure
The American Journal of Cardiology, 10/28/09
Relevance Score: 89%
Comparison of Bleeding Complications With Omega-3 Fatty Acids + Aspirin + Clopidogrel—Versus—Aspirin + Clopidogrel in Patients With Cardiovascular Disease
The American Journal of Cardiology, 10/13/09
Relevance Score: 89%
Gender and Responses to Aspirin and Clopidogrel: Insights Using Short Thrombelastography
Cardiovascular Drug Reviews, 11/17/09
Relevance Score: 87%
Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Vascular Health and Risk Management, 10/22/09
Relevance Score: 87%
Effects of clopidogrel on aspirin specific pathways of platelet inhibition
Platelets, 10/02/09
Relevance Score: 87%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study
Clinical Drug Investigation, 12/11/09
Doxorubicin Cardiomyopathy
Cardiology, 12/11/09
Recent Caffeine Ingestion Reduces Adenosine Efficacy in the Treatment of Paroxysmal Supraventricular Tachycardia
Academic Emergency Medicine, 12/11/09
Today in Myocardium/Pericardium...keeping you current
Receive free subspecialty "5-minute updates" via email
Stem cell therapy in acute myocardial infarction: a review of clinical trials
Translational Research, The Journal of Laboratory and Clinical Medicine, 12/11/09
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study
Blood Pressure, 12/11/09
Doxorubicin Cardiomyopathy
Cardiology, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


